Showing results (121-130 of 150) with videos related to

Sort By:
Pageof 15
Nature Communications|December 23, 2017
Glutaminolysis drives membrane trafficking to promote invasiveness of breast cancer cellsEmmanuel Dornier, Nicolas Rabas, Louise Mitchell, et al.
Breast Cancer Research : BCR|January 2, 2020
A phase I/II study of epertinib plus trastuzumab with or without chemotherapy in patients with HER2-positive metastatic breast cancerIain R Macpherson, Pavlina Spiliopoulou, Saeed Rafii, et al.
Molecular Cancer Therapeutics|October 14, 2003
Anti-angiogenic activity of human endostatin is HIF-1-independent in vitro and sensitive to timing of treatment in a human saphenous vein assayGordon R Macpherson, Sylvia S W Ng, Siiri L Forbes, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|December 10, 2019
Dynamic Changes in High-Sensitivity Cardiac Troponin I in Response to Anthracycline-Based ChemotherapyE Tzolos, P D Adamson, P S Hall, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 29, 2017
Distinctive roles of age, sex, and genetics in shaping transcriptional variation of human immune responses to microbial challengesBarbara Piasecka, Darragh Duffy, Alejandra Urrutia, et al.
Breast (Edinburgh, Scotland)|April 9, 2026
Understanding the patient journey: Barriers, facilitators, and expectations in joining a chemotherapy de-escalation trial among premenopausal patients with breast cancerPetya Zyumbileva, Tanja Spanic, Emma Gillanders, et al.
AIDS (London, England)|December 6, 2022
Association between ten-eleven methylcytosine dioxygenase 2 genetic variation and viral load in people with HIVDaniel D Murray, Birgit Grund, Cameron R MacPherson, et al.
AIDS Research and Therapy|May 2, 2024
The association between single-nucleotide polymorphisms within type 1 interferon pathway genes and human immunodeficiency virus type 1 viral load in antiretroviral-naïve participantsSara Bohnstedt Mørup, Preston Leung, Cavan Reilly, et al.
Frontiers in Molecular Biosciences|December 22, 2023
Predicting type 2 diabetes risk before and after solid organ transplantation using polygenic scores in a Danish cohortQuenia Dos Santos, Preston Leung, Christian W Thorball, et al.
European Journal of Cancer (Oxford, England : 1990)|March 31, 2015
Regorafenib plus modified FOLFOX6 as first-line treatment of metastatic colorectal cancer: A phase II trialGuillem Argilés, Mark P Saunders, Fernando Rivera, et al.
Pageof 15